Literature DB >> 4645785

Inhibition of phenylbutazone elimination by its metabolite oxyphenbutazone.

E Jähnchen, G Levy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4645785     DOI: 10.3181/00379727-141-36911

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  11 in total

1.  Effect of single and multiple treatments with phenylbutazone in normal and adjuvant-induced polyarthritic rats.

Authors:  H DiPasquale; C Rassaert; P Welaj; J Gingold
Journal:  Agents Actions       Date:  1975-02

Review 2.  The use of kinetic-dynamic interactions in the evaluation of drugs.

Authors:  D B Campbell
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.

Authors:  Christopher Louizos; Jaime A Yáñez; M Laird Forrest; Neal M Davies
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

4.  Pharmacokinetic modeling of heparin and its clinical implications.

Authors:  T J McAvoy
Journal:  J Pharmacokinet Biopharm       Date:  1979-08

5.  Clearance of diazepam can be impaired by its major metabolite desmethyldiazepam.

Authors:  U Klotz; I Reimann
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

6.  Inhibitory effects of intravenous chloramphenicol sodium succinate on the disposition of phenylbutazone in horses.

Authors:  D F Gerken; R A Sams
Journal:  J Pharmacokinet Biopharm       Date:  1985-10

Review 7.  Drug metabolites in renal failure: pharmacokinetic and clinical implications.

Authors:  R K Verbeeck; R A Branch; G R Wilkinson
Journal:  Clin Pharmacokinet       Date:  1981 Sep-Oct       Impact factor: 6.447

8.  The unsteady model. An alternative approach to nonlinear pharmacokinetics.

Authors:  M T Smith; T C Smith
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

9.  Dose dependent pharmacokinetics of prednisolone.

Authors:  M E Pickup; J R Lowe; P A Leatham; V M Rhind; V Wright; W W Downie
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

10.  Hepatic clearance of drugs. II. Experimental evidence for acceptance of the "well-stirred" model over the "parallel tube" model using lidocaine in the perfused rat liver in situ preparation.

Authors:  K S Pang; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1977-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.